DEAD

Serial Number

87376446

Owner

Metuchen Pharmaceuticals LLC

Attorney

Mark Pohl

First Use Date

Mar 25, 2018

Filing Date

Mar 18, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

STENDRA (AVANAFIL) TABLETS Trademark

Serial Number: 87376446

STENDRA (AVANAFIL) TABLETS is a trademark filed by Metuchen Pharmaceuticals LLC on March 18, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Metuchen Pharmaceuticals LLC (11 trademarks)

1st floor
Cranford, NJ 07016

Entity Type: 16

Legal Representation

Attorney of Record

Mark Pohl

86 trademarks filed View all →

Correspondence Address

MARK POHL PHARMACEUTICAL PATENT ATTORNEYS, LLC

55 MADISON AVENUE

4TH FLOOR

MARK POHL (P4014)

MORRISTOWN

Trademark Details

Filing Date

March 18, 2017

Registration Date

Not Registered

First Use Anywhere

March 25, 2018

First Use in Commerce

March 25, 2018

Published for Opposition

September 5, 2017

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jan 30, 2019 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jan 29, 2019 ABN2

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 3, 2018 GNRN

NON-FINAL ACTION E-MAILED

Jul 3, 2018 GNRT

SU - NON-FINAL ACTION - WRITTEN

Jul 3, 2018 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Apr 12, 2018 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 12, 2018 AITU

USE AMENDMENT FILED

Mar 25, 2018 IUAF

TEAS STATEMENT OF USE RECEIVED

Mar 25, 2018 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 31, 2017 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 5, 2017 NPUB

PUBLISHED FOR OPPOSITION

Sep 5, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 16, 2017 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 24, 2017 CNSA

EXAMINER'S AMENDMENT ENTERED

Jul 24, 2017 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 24, 2017 GNEN

EXAMINERS AMENDMENT E-MAILED

Jul 24, 2017 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jul 24, 2017 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 22, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 22, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 22, 2017 TROA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 28, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 28, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 28, 2017 TROA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 27, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 27, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 27, 2017 TROA

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Jun 23, 2017 GEAN

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Jun 23, 2017 GEAP

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

Jun 23, 2017 EPEN

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

Jun 23, 2017 CPEA

ASSIGNED TO EXAMINER

Jun 12, 2017 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 24, 2017 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 23, 2017 NWOS

NEW APPLICATION ENTERED

Mar 22, 2017 NWAP

Related Trademarks

More from this Owner

PETROS

METUCHEN PHARMACEUTICALS

PETROS PHARMACEUTICALS

HEALTH CARE FOR MEN

METUCHEN PHARMACEUTICALS

More in Same Class

VITHINK

WELLNESS CENTER BEFORE & AFTER WEIGHT LOSS

HEMPFUSION HEMP AID

HEMPFUSION

HEMPFUSION HEMP SLEEP

PURELY POSITIVE, INSIDE AND OUT